Cholecystokinin-B (CCK-B) receptor antagonists improve "aged" sleep: a new class of sleep modulators?

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Methods and Findings in Experimental and Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1358/MF.1999.21.1.527016PMID 10222445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Triazolam-induced sleep in the rat: influence of prior sleep, circadian time, and light/dark cycles

  2005cited by this paper
• CCKB receptor activation reduces glutamate-induced depolarization in slices of rat cerebral cortex

  2005cited by this paper
• Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats

  2004cited by this paper
• Zolpidem: Distinct from Triazolam?

  1997cited by this paper
• Cholecystokinin-GABA interactions in rat striatum.

  1995cited by this paper
• Inhibition of nitric oxide synthesis inhibits rat sleep.

  1994cited by this paper
• Nitric oxide synthase inhibition reduces wakefulness.

  1994cited by this paper
• Biological actions of cholecystokinin.

  1994cited by this paper
• Benzodiazepines promote the intermediate stage at the expense of paradoxical sleep in the rat.

  1994cited by this paper
• ABC of sleep disorders. Impact and epidemiology of sleep disorders.

  1993cited by this paper
• ABC of sleep disorders. Sleep and sleep problems in elderly people.

  1993cited by this paper
• Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.

  1993cited by this paper
• Effect of a highly selective central CCK-B receptor agonist: BC-264 on rat sleep.

  1991cited by this paper
• Intraperitoneal injection of cholecystokinin elicits sleep in rabbits.

  1991cited by this paper
• Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329

  1990cited by this paper
• Excitatory amino acid receptors and synaptic plasticity.

  1990cited by this paper
• Effects of melatonin on vertebrate circadian systems.

  1990cited by this paper
• Apneic effects of cholecystokinin in unanaesthetized fetal sheep.

  1990cited by this paper
• Does cholecystokinin induce physiological satiety and sleep?

  1989cited by this paper
• Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.

  1989cited by this paper
• Effects of nocturnal intraperitoneal administration of cholecystokinin in rats: simultaneous increase in sleep, increase in EEG slow-wave activity, reduction of motor activity, suppression of eating, and decrease in brain temperature.

  1988cited by this paper
• Pharmacotherapy of insomnia.

  1987cited by this paper
• Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists

  1987cited by this paper
• In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.

  1987cited by this paper
• Hypnotics: clinical value of pharmaco-EEG methods.

  1986cited by this paper
• Effect of chronic intracerebroventricular infusion of cholecystokinin on respiration and sleep.

  1986cited by this paper
• Nocturnal sleep and wakefulness: effects of age and sex in normal sleepers.

  1984cited by this paper
• Age-related changes in the sleep pattern of male adult rats.

  1983cited by this paper
• A benzodiazepine receptor antagonist decreases sleep and reverses the hypnotic actions of flurazepam.

  1983cited by this paper
• Dopamine modulates cholecystokinin release in neostriatum

  1983cited by this paper
• Monoamine changes in the brain of cats during slow-wave sleep.

  1976cited by this paper
• [Monoamines and the regulation of wakefulness. I. Contribution and biochemical interpretation of the polygraphic data].

  1972cited by this paper

• QSAR Modeling of CCK2 Receptor Antagonists Utilizing Computed Structural Indices

  2019cites this paper
• Effect of Heweianshen Decoction on Orexin-A and Cholecystokinin-8 Expression in Rat Models of Insomnia

  2016cites this paper
• Architecture in the Rat A Two-State Stochastic Model of REM Sleep

  2015cites this paper
• Neuroscience-driven discovery and development of sleep therapeutics.

  2014cites this paper
• GABA and Sleep

  2010influential citation
• Sleep and Its Modulation by Substances That Affect GABAA Receptor Function

  2010cites this paper
• The role of neuropeptides in sleep modulation.

  2004cites this paper
• Ganglioside Patterns Mature at Different Rates in Functionally Related Subregions of the Rat Pons

  2003cites this paper
• Biochemical regulation of non-rapid-eye-movement sleep.

  2003cites this paper
• Behavioral effects of acute and chronic triazolam treatments in albino rats.

  2003cites this paper
• Cholecystokinin antagonists: Pharmacological and therapeutic potential

  2003cites this paper
• A two-state stochastic model of REM sleep architecture in the rat.

  2002cites this paper
• CCK2 receptor antagonists

  2001cites this paper
• The Influence of Subchronic Administration of the Neurosteroid Allopregnanolone on Sleep in the Rat

  2001cites this paper
• γ-Aminobutyric AcidA (GABAA) Agonist 4,5,6,7-Tetrahydroisoxazolo[4,5-c]pyridin-3-ol Persistently Increases Sleep Maintenance and Intensity during Chronic Administration to Rats

  2000cites this paper
• New Trends In Insomnia Management

  1999cites this paper
• Evaluation of Severe Insomnia In The General Population – Implications for The Management of Insomnia: Focus on Results From Ireland

  1999cites this paper
• Agitation in the ICU: part one Anatomical and physiologic basis for the agitated state

  1999cites this paper